{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:32:12Z","timestamp":1787819532712,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.det.2016.11.012","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T02:22:37Z","timestamp":1489717357000},"page":"235-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Role of Diet and Supplements in Vitiligo Management"],"prefix":"10.1016","volume":"35","author":[{"given":"Pearl E.","family":"Grimes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Nashawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2016.11.012_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.det.2016.11.012_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.12998\/wjcc.v3.i3.221","article-title":"Highlights in pathogenesis of vitiligo","volume":"3","author":"Mohammed","year":"2015","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.det.2016.11.012_bib3","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1 Suppl","key":"10.1016\/j.det.2016.11.012_bib4","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jaad.2004.01.007","article-title":"White patches and bruised souls: advances in the pathogenesis and treatment of vitiligo","volume":"51","author":"Grimes","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.11.012_bib5","article-title":"Vitiligo: pathogenesis, clinical features, and diagnosis","author":"Grimes","year":"2016"},{"issue":"4","key":"10.1016\/j.det.2016.11.012_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.0022-202x.2001.01459.x","article-title":"Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo","volume":"117","author":"Dell'Anna","year":"2001","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.11.012_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/1523-1747.ep12363163","article-title":"Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma","volume":"107","author":"Picardo","year":"1996","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.11.012_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0749.1992.tb00003.x","article-title":"Catecholamines and vitiligo","volume":"5","author":"Morrone","year":"1992","journal-title":"Pigment Cell Res"},{"issue":"2","key":"10.1016\/j.det.2016.11.012_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenae","year":"2003","journal-title":"Pigment Cell Res"},{"issue":"223","key":"10.1016\/j.det.2016.11.012_bib10","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.det.2016.11.012_bib11","unstructured":"Ortonne JP. Pathogenesis of vitiligo. In: Gupta S, Olsson MJ, Kanwar AJ, et al, editors. Surgical Management of Vitiligo 2008; p. 4\u201310."},{"issue":"3","key":"10.1016\/j.det.2016.11.012_bib12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1523-1747.2003.12413.x","article-title":"Cytotoxic T lymphocyte reactivity to gp100, MelanA\/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients","volume":"121","author":"Mandelcorn-Monson","year":"2003","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2016.11.012_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0378-6323.48654","article-title":"Vitiligo and diet: a theoretical molecular approach with practical implications","volume":"75","author":"Namazi","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.det.2016.11.012_bib14","series-title":"Vitiligo: management and therapy","article-title":"Complementary and alternative medicine for vitiligo","author":"Yoon","year":"2011"},{"key":"10.1016\/j.det.2016.11.012_bib15","first-page":"200","article-title":"Vitiligo and autoantibodies of celiac disease","volume":"4","author":"Shahmoradi","year":"2013","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.det.2016.11.012_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000370303","article-title":"Rapid partial repigmentation of vitiligo in a young female adult with a gluten-free diet","volume":"6","author":"Khandavala","year":"2014","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.det.2016.11.012_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1525-1470.2011.01388.x","article-title":"Repigmentation of vitiligo lesions in a child with celiac disease after a gluten-free diet","volume":"28","author":"Rodriguez-Garcia","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2016.11.012_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00244-015-0138-7","article-title":"Correlation of serum thyroid hormones autoantibodies with self-reported exposure to thyroid disruptors in a group of nonsegmental vitiligo patients","volume":"69","author":"Colucci","year":"2015","journal-title":"Arch Environ Contam Toxicol"},{"issue":"1","key":"10.1016\/j.det.2016.11.012_bib19","first-page":"39","article-title":"Folic acid and vitamin B12 in vitiligo: a nutritional approach","volume":"50","author":"Montes","year":"1992","journal-title":"Cutis"},{"key":"10.1016\/j.det.2016.11.012_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3349\/ymj.1999.40.3.195","article-title":"Serum levels of folic acid and vitamin B12 in Korean patients with vitiligo","volume":"40","author":"Kim","year":"1999","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.det.2016.11.012_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/0378-6323.66611","article-title":"Serum vitamin B12, folate, ferritin, and iron levels in Turkish patients with vitiligo","volume":"76","author":"Gonul","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.det.2016.11.012_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1684\/ejd.2009.0671","article-title":"Serum homocysteine, folic acid, and vitamin B12 levels in vitiligo","volume":"19","author":"Balci","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.det.2016.11.012_bib23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2340\/000155555577460462","article-title":"Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure","volume":"77","author":"Juhlin","year":"1977","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2016.11.012_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/000155502320624113","article-title":"Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12","volume":"82","author":"Tijoe","year":"2002","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.det.2016.11.012_bib25","first-page":"4","article-title":"Ascorbic acid in vitiligo","volume":"26","author":"Bhattacharya","year":"1981","journal-title":"Indian J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.012_bib26","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jama.293.6.730","article-title":"New insights and new therapies in vitiligo","volume":"293","author":"Grimes","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.det.2016.11.012_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.semnephrol.2003.08.018","article-title":"Vitamin D receptor and analogs","volume":"24","author":"Dusso","year":"2004","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.det.2016.11.012_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4103\/0378-6323.120720","article-title":"The role of vitamin D in melanogenesis with an emphasis on vitiligo","volume":"79","author":"AlGhamdi","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"6","key":"10.1016\/j.det.2016.11.012_bib29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2009.11.024","article-title":"A\u00a0pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris","volume":"62","author":"Silverberg","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.11.012_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/phpp.12016","article-title":"Evaluation of serum 25-hydroxyvitamin D levels in vitiligo patients with and without autoimmune diseases","volume":"29","author":"Saleh","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"12","key":"10.1016\/j.det.2016.11.012_bib31","doi-asserted-by":"crossref","first-page":"e52778","DOI":"10.1371\/journal.pone.0052778","article-title":"Serum 25-hydroxyvitamin D deficiency in Chinese patients with vitiligo: a case-control study","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.det.2016.11.012_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/derm.24808","article-title":"A\u00a0pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis","volume":"5","author":"Finamor","year":"2013","journal-title":"Dermatoendocrinol"},{"issue":"21","key":"10.1016\/j.det.2016.11.012_bib33","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1021\/ja00411a035","article-title":"Autoxidation of biological molecules. 1. Antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in\u00a0vitro","volume":"103","author":"Burton","year":"1981","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.det.2016.11.012_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000342124","article-title":"The antioxidant role of paraoxonase 1 and vitamin E in three autoimmune diseases","volume":"26","author":"Ramadan","year":"2013","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.det.2016.11.012_bib35","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0091270009335769","article-title":"Response of vitiligo to narrowband ultraviolet B and oral antioxidants","volume":"49","author":"Elgoweini","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.det.2016.11.012_bib36","first-page":"24","article-title":"The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA","volume":"12","author":"Akyol","year":"2001","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.012_bib37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2230.2007.02514.x","article-title":"Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial","volume":"32","author":"Dell'Anna","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2016.11.012_bib38","unstructured":"Lipoic Acid | Linus Pauling Institute | Oregon State University [Internet]. Lpi.oregonstate.edu. 2016. Available at: http:\/\/lpi.oregonstate.edu\/mic\/dietary-factors\/lipoic-acid. Accessed June 15, 2016."},{"issue":"1","key":"10.1016\/j.det.2016.11.012_bib39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/pr050361j","article-title":"Counting the zinc-proteins encoded in the human genome","volume":"5","author":"Andreini","year":"2006","journal-title":"J\u00a0Proteome Res"},{"issue":"1 Suppl","key":"10.1016\/j.det.2016.11.012_bib40","first-page":"93","article-title":"Zinc: an overview","volume":"11","author":"Prasad","year":"1994","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.det.2016.11.012_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/0378-6323.16243","article-title":"Serum zinc level in vitiligo: a case control study","volume":"71","author":"Shameer","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.det.2016.11.012_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-5945-11-7","article-title":"Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial","volume":"11","author":"Yaghoobi","year":"2011","journal-title":"BMC Dermatol"},{"issue":"5","key":"10.1016\/j.det.2016.11.012_bib43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4103\/0019-5154.87116","article-title":"Hypothesis: zinc can be effective in treatment of vitiligo","volume":"56","author":"Bagherani","year":"2011","journal-title":"Indian J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.11.012_bib44","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/ptr.3345","article-title":"Antiinflammatory activity of Phyllanthus emblica, Plumbago zeylanica and Cyperus rotundus in acute models of inflammation","volume":"25","author":"Dang","year":"2011","journal-title":"Phytother Res"},{"key":"10.1016\/j.det.2016.11.012_bib45","first-page":"676","article-title":"Antioxidant activity of active tannoid principles of Emblica officinalis (amla)","volume":"37","author":"Arunabh Bhattacharya","year":"1999","journal-title":"Indian J Exp Biol"},{"issue":"9","key":"10.1016\/j.det.2016.11.012_bib46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14786410601124664","article-title":"Studies on the chemical constituents of Phyllanthus emblica","volume":"21","author":"Habib-ur-Rehman","year":"2007","journal-title":"Nat Prod Res"},{"issue":"1","key":"10.1016\/j.det.2016.11.012_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/dth.12172","article-title":"Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E, and carotenoids in vitiligo treatment","volume":"28","author":"Colucci","year":"2015","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2016.11.012_bib48","unstructured":"The proposed mechanisms of action for Ginkgo [Internet]. Ebmconsult.com. 2016. Available at: http:\/\/www.ebmconsult.com\/articles\/ginkgo-biloba-mechanism-of-action-moa. Accessed June 15, 2016."},{"issue":"3","key":"10.1016\/j.det.2016.11.012_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2230.2003.01207.x","article-title":"Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo","volume":"28","author":"Parsad","year":"2003","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.11.012_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6882-11-21","article-title":"Ginkgo biloba for the treatment of vitiligo vulgaris: an open label pilot clinical trial","volume":"11","author":"Szczurko","year":"2011","journal-title":"BMC Complement Altern Med"},{"issue":"6","key":"10.1016\/j.det.2016.11.012_bib51","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jaad.2004.06.027","article-title":"Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin","volume":"51","author":"Middelkamp-Hup","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.11.012_bib52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00403-014-1535-x","article-title":"Current knowledge in Polypodium leucotomos effect on skin protection","volume":"307","author":"Palomino","year":"2015","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.det.2016.11.012_bib53","first-page":"254","article-title":"Polypodium leucotomos extract: a status report on clinical efficacy and safety","volume":"14","author":"Winkelmann","year":"2015","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.det.2016.11.012_bib54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-4362.1989.tb02517.x","article-title":"Vitiligo repigmentation with Anapsos (Polypodium leucotomos)","volume":"28","author":"Mohammad","year":"1989","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.11.012_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jdermsci.2005.12.006","article-title":"Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: a pilot study","volume":"41","author":"Reyes","year":"2006","journal-title":"J\u00a0Dermatol Sci"},{"issue":"3","key":"10.1016\/j.det.2016.11.012_bib56","first-page":"13","article-title":"Polypodium leucotomos as an adjunct treatment of pigmentary disorders","volume":"7","author":"Nestor","year":"2014","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"7","key":"10.1016\/j.det.2016.11.012_bib57","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1468-3083.2006.02132.x","article-title":"Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study","volume":"21","author":"Middelkamp-Hup","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.det.2016.11.012_bib58","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1751-1097.2006.tb09809.x","article-title":"UV irradiation affects melanocyte stimulatory activity and protein binding of piperine","volume":"82","author":"Soumyanath","year":"2006","journal-title":"Photochem Photobiol"},{"issue":"7","key":"10.1016\/j.det.2016.11.012_bib59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1055\/s-1999-14031","article-title":"Stimulation of mouse melanocyte proliferation by Piper nigrum fruit extract and its main alkaloid, piperine","volume":"65","author":"Lin","year":"1999","journal-title":"Planta Med"},{"issue":"8","key":"10.1016\/j.det.2016.11.012_bib60","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.bmc.2004.01.036","article-title":"Effects of piperine analogues on stimulation of melanocyte proliferation and melanocyte differentiation","volume":"12","author":"Venkatasamy","year":"2004","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"10.1016\/j.det.2016.11.012_bib61","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2133.2008.08464.x","article-title":"In\u00a0vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model","volume":"158","author":"Faas","year":"2008","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.11.012_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mam.2011.10.001","article-title":"Green tea EGCG, T cells, and T cell-mediated autoimmune diseases","volume":"33","author":"Wu","year":"2012","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.det.2016.11.012_bib63","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fitote.2014.08.007","article-title":"The therapeutic effects of EGCG on vitiligo","volume":"99","author":"Zhu","year":"2014","journal-title":"Fitoterapia"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863516301395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863516301395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:44:38Z","timestamp":1692726278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863516301395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0733863516301395"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2016.11.012","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Diet and Supplements in Vitiligo Management","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2016.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}